Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

993447

registered interest
date	23/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Flour: Folic Acid
house id	1
legislature	25259 pref label House of Commons
question text	What progress he has made on implementing proposals for the mandatory fortification of flour with folic acid.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	907229
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>The Government is continuing to review advice from our expert advisory groups on safe levels of folate intake. Alongside this, we will be issuing a public consultation on the issue of adding folic acid to flour. This will explore this complex issue in detail and allow us to take an informed decision on whether to introduce mandatory fortification of flour. We will announce the date for the consultation soon.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:43:47 answering member 4067 label Biography information for Steve Brine
tabling member	4393 label Biography information for Stuart C McDonald

993448

registered interest
date	23/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Foetal Alcohol Spectrum Disorder
house id	1
legislature	25259 pref label House of Commons
question text	What assessment he has made of the proportion of children born in the UK with foetal alcohol spectrum disorders in each of the last five years.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	907231
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>Foetal alcohol syndrome disorders can have a significant impact on the early years development of children, their behaviours and their life chances.</p><p>Public Health England collects some data on fetal alcohol sydrome, but we recognise that this data does not reflect the range of fetal alcohol spectrum disorders (FASD), as these are very difficult to diagnose. That is why we are engaging experts and those affected by FASD to explore what more could be done to improve our understanding.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:44:55 answering member 4067 label Biography information for Steve Brine
tabling member	4061 label Biography information for Bill Esterson

992635

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has he made of the effect of leaving the EU on food standards in the UK.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	182092
answer	answer is ministerial correction date of answer 25/10/2018 answer text <p>The Government, including the Food Standards Agency, is committed to maintaining the United Kingdom’s high standard of food safety and ensuring we take a risk-based, proportionate approach that prioritises public health and the interests of consumers. We are investigating a range of solutions to ensure that from day one, food is as safe as it is now. Maintaining a robust and effective regulatory regime for ensuring the safety of food remains a high priority as the UK prepares to leave the European Union.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/10/2018 11:27:49 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

992638

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 May 2018 to Question 142448 on Postnatal Care, whether the General Medical Services contract sets out that GPs must provide the (a) six week postnatal check for new mothers and (b) six to eight week check for babies.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182198
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>A six-week postnatal check for all mothers and a six to eight-week check for all babies are not currently specified in the General Medical Services contract as something which general practitioners are required to provide. However, we have asked for the six-week maternal postnatal check, as recommended by the National Childbirth Trust, to be considered in the general practice contract negotiations for 2019/20.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:53:20 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992640

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to assess the effect of NICE’s Highly Specialised Technologies process on patients in the UK with rare diseases.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182200
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>To date, the National Institute for Health and Care Excellence (NICE) has recommended all eight medicines that it has evaluated through its highly specialised technologies (HST) programme for some or all of the eligible patient population, in most cases subject to managed access agreements that specify clinical criteria and data collection requirements. National Health Service organisations are legally required to fund medicines recommended in NICE’s HST guidance, and patients with the rare diseases concerned are now benefitting from access to the medicines in line with NICE’s recommendations.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 182202 question first answered 30/10/2018 15:52:26 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992641

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether treatments for rare diseases approved under the Highly Specialised Technologies (HST) process would have been rejected under the new criteria introduced for the HST process in 2017.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182201
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>The National Institute for Health and Care Excellence has advised that prior to the revised methods for the development of highly specialised technology (HST) evaluation guidance being introduced in 2017, the HST programme did not have a cost-effectiveness framework to inform the consideration of value for money. Therefore it is not possible to confirm if those technologies that were evaluated before April 2017 would have been recommended under the new methods, because the key elements of the new methods were not established and were not considered by the committee in the context of the many other factors taken into account in the decision-making.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:49:43 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992642

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the (a) criteria used for and (b) long term data collection requirement of the highly specialised technologies process.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182202
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>To date, the National Institute for Health and Care Excellence (NICE) has recommended all eight medicines that it has evaluated through its highly specialised technologies (HST) programme for some or all of the eligible patient population, in most cases subject to managed access agreements that specify clinical criteria and data collection requirements. National Health Service organisations are legally required to fund medicines recommended in NICE’s HST guidance, and patients with the rare diseases concerned are now benefitting from access to the medicines in line with NICE’s recommendations.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 182200 question first answered 30/10/2018 15:52:26 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992643

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many successful applications there have been (a) to NHS England’s individual funding requests for specialised services and (b) through the clinically critically urgent criteria process since January 2018.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182203
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>The number of successful individual funding requests since January 2018 is less than 10, and the true figure has been withheld to protect patient confidentiality. The critically urgent criteria process and decision making ceased on publication of the Specialised Commissioning Service Development Policy, which was published by NHS England on 12 September 2017.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:56:29 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992648

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer: Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to improve the provision of prostate radiotherapy in the NHS for patients with advanced prostate cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182208
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>NHS England is aware of newly published research data (STAMPEDE trial) published in the Lancet in October 2018. The article provides the results of the study which identifies a subgroup of prostate cancer patients with a newly diagnosed metastatic prostate cancer and with a low metastatic burden that may benefit from treatment using radiotherapy.</p><p> </p><p>NHS England has received a policy proposition proposal to develop a clinical commissioning policy for this treatment and a policy working group will be established to take this forward.</p><p> </p><p>The Lancet article is available at the following link:</p><p> </p><p><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32486-3/fulltext" target="_blank">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32486-3/fulltext</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:57:43 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992649

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Males
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the effects of type 2 diabetes in men.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182209
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>NHS England has committed to delivering the NHS Diabetes Prevention Programme to up to 100,000 people per year, from 2020, supporting those at high risk of type 2 diabetes to reduce their risk through attending a lifestyle programme. The programme supports individuals in achieving a healthy weight, improving quality of nutrition and increasing physical activity. In 2017/18 the Programme also focused on pump-priming investment by local services to deliver evidence based interventions for people living with both type 1 and type 2 diabetes.</p><p> </p><p>Whilst this programme is not targeting men specifically, local health economies have been required to consider current local inequalities when delivering services and there are signs that both of these workstreams are achieving positive outcomes for men.</p><p> </p><p>In order to achieve this, NHS England has invested approximately £10 million per annum over financial years 2017/18 and 2018/19 for the development of hospital multidisciplinary diabetic foot services where they do not exist in England, and to expand capacity in pre-existing services where additional capacity is required. This has resulted in investment in 41 multidisciplinary diabetic foot services nationally, representing 137 additional staff. The investment forms part of a wider programme to improve the outcomes of men and women with diabetes. This investment will keep improving outcomes for men who are also at significantly higher risk of developing diabetic foot disease.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:54:20 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon